Green Cross (South Korean company)

Green Cross Corporation (녹십자, Nok Sip Ja) is a South Korean biopharmaceutical company headquartered in Yongin, South Korea. Founded in 1967 as Korea Green Cross, it is primarily engaged in the development, manufacturing, and distribution of biopharmaceutical products, including vaccines, plasma derivatives, and recombinant proteins.

History:

The company was established with a focus on blood products and has since expanded its portfolio to encompass a wide range of therapeutic areas, including infectious diseases, oncology, and immunology. Over the years, Green Cross has played a significant role in South Korea's public health initiatives, particularly in the prevention and treatment of vaccine-preventable diseases.

Products and Services:

Green Cross's product line includes:

• Vaccines: Vaccines for various diseases, including influenza, varicella (chickenpox), hepatitis A, and Japanese encephalitis.
• Plasma Derivatives: Products derived from human plasma, such as immunoglobulins (IVIG), albumin, and coagulation factors for the treatment of bleeding disorders.
• Recombinant Proteins: Biopharmaceuticals produced using recombinant DNA technology, including erythropoietin (EPO) and growth factors.
• Diagnostic Reagents: Diagnostic products used for detecting and monitoring various medical conditions.

Global Presence:

While primarily based in South Korea, Green Cross has expanded its operations internationally, establishing partnerships and distribution networks in various regions.

Recent Developments:

Green Cross has been actively involved in the development of vaccines and therapies for emerging infectious diseases.